Get started
Conduit Pharmaceuticals Inc.Conduit Pharmaceuticals Inc.Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

CDT chart


Full chart

Key stats


Market capitalization
‪8.56 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−21.2760 USD
Net income (FY)
‪−17.80 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪8.35 M‬
Beta (1Y)
0.91

Employees


Employees (FY)
6
Change (1Y)
−1 −14.29%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−2.97 M‬ USD

About Conduit Pharmaceuticals Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
David Joszef Tapolczay
Website
conduitpharma.com
Headquarters
Naples
FIGI
BBG015879ML2
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CDT news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CDT.

Frequently Asked Questions


The current price of CDT is 0.7880 USD — it has decreased by −12.09% in the past 24 hours. Watch Conduit Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Conduit Pharmaceuticals Inc. stocks are traded under the ticker CDT.
CDT stock has risen by 34.11% compared to the previous week, the month change is a −27.03% fall, over the last year Conduit Pharmaceuticals Inc. has showed a −99.75% decrease.
CDT reached its all-time high on Sep 19, 2023 with the price of 2,500.0000 USD, and its all-time low was 0.5100 USD and was reached on Apr 9, 2025. View more price dynamics on CDT chart.
See other stocks reaching their highest and lowest prices.
CDT stock is 32.89% volatile and has beta coefficient of 0.91. Track Conduit Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Conduit Pharmaceuticals Inc. there?
Today Conduit Pharmaceuticals Inc. has the market capitalization of ‪8.56 M‬, it has decreased by −9.54% over the last week.
Yes, you can track Conduit Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
CDT net income for the last quarter is ‪−2.41 M‬ USD, while the quarter before that showed ‪−6.46 M‬ USD of net income which accounts for 62.76% change. Track more Conduit Pharmaceuticals Inc. financial stats to get the full picture.
No, CDT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 16, 2025, the company has 6 employees. See our rating of the largest employees — is Conduit Pharmaceuticals Inc. on this list?
Like other stocks, CDT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Conduit Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Conduit Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Conduit Pharmaceuticals Inc. stock shows the sell signal. See more of Conduit Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.